期刊文献+

How to explore the effects of sex hormone on blood vessels

How to explore the effects of sex hormone on blood vessels
下载PDF
导出
摘要 The risk of cardiovascular disease increases along with aging. There are increasing interests in researches on the protective effects of hormone replacement therapy (HRT)on cardiovascular system in postmenopausal women. In this article we will review how we have explored the evidence of different sex hormones on blood vessels since 1996. The results showed that low-dose HRT significantly protected cardiovascular system in postmenopausal women.However, the high-dose 17β-estradiol (E2), with or without progesterone (P) or testosterone (T), or any hormone alone, as their concentrations increase, may even inhibit the protective effects of low-dose HRT on blood vessels. The risk of cardiovascular disease increases along with aging. There are increasing interests in researches on the protective effects of hormone replacement therapy (HRT) on cardiovascular system in postmenopausal women. In this article we will review how we have explored the evidence of different sex hormones on blood vessels since 1996. The results showed that low-dose HRT significantly protected cardiovascular system in postmenopausal women. However, the high-dose 17β-estradiol (E2), with or without progesterone (P) or testosterone (T),or any hormone alone, as their concentrations increase, may even inhibit the protective effects of low-dose HRT on blood vessels.
出处 《生殖医学杂志》 CAS 2004年第z1期75-78,共4页 Journal of Reproductive Medicine
关键词 HORMONE replacement therapy 17Β-ESTRADIOL PROGESTERONE TESTOSTERONE Tissue factor POSTMENOPAUSAL women Hormone replacement therapy 17β-estradiol Progesterone Testosterone Tissue factor Postmenopausal women
  • 相关文献

参考文献5

二级参考文献30

  • 1桑国卫,邵庆翔,乌毓明,郑淑蓉,杜明昆,吴熙瑞,武淑英,翁梨驹,范慧民,王幼劬,韩向阳,段云葵,陈孝婉,李敬之,王芝芬,郭淑清,吴学浙,卢玉兰,程利南,金毓翠,王亮,汪永顺,许烨,刘慧,丁慧娟,罗永明,王峰,方慧兰,韩字研,雷贞武,陈学煌,周曾娣.不同剂量米非司酮配伍卡孕栓终止早孕的Ⅲ期临床试验[J].中华医学杂志,1996,76(5):325-330. 被引量:58
  • 2上海市口服避孕药协作组.减量口服避孕药的临床和实验研究[A]..上海市避孕药参考资料[C].,1978.77-98. 被引量:2
  • 3Writing group for the Women's Health Initiative Investigators. Risks and benefits of estrogen plus progestin in healthy postmenopausal women. Principal results from the women's health initiative randomized controlled trial[J]. JAMA, 2002,288(3):321-333. 被引量:1
  • 4Gallagher JC, Baylink DJ, Freeman R, et al. Prevention of bone loss with tibolone in postmenopausal women: results of two randomized double-blind, placebo-controlled, dose-finding studies[J].J Clin Endocrinol Metab,2001,86(10):4717-4726. 被引量:1
  • 5Fitzpatrick LD, Nachtigall LE. Low dose: a new era for hormone therapy[J]? Menopause Management,2004,13(1):54-56. 被引量:1
  • 6Ossewaarde ME,Dallinga Thie GM,Bots ML,et al. Treatment with hormone replacement therapy lowers remnant lipoprotein particles in healthy postmenopausal women : results from a randomized trial [J]. Eur J Clin Invest, 2003,33 (5):376-382. 被引量:1
  • 7Writing group for the women's Health Initiative Investigators. Risks and benefits of estrogen plus progestin in healthy postmenopausal women:principal results from the Women's Health Initiative randomized controlled trial [J]. J Am Med Assoc, 2002, 288(3) 被引量:1
  • 8Hu FB, Grodstein F. Postmenopausal hormone therapy and the risk of cardiovascular disease: the epidemiologic evidence [J]. Am J Cardiol, 2002, 90 (1A): 22F-25F. 被引量:1
  • 9Schneider HPG. The view of the international menopause society on the Women's Health Initiative[J]. Climacteric, 2002, 5(3): 211-216. 被引量:1
  • 10Knopp RH. Risk factors for coronary artery disease in women [J]. Am J Cardiol, 2002, 89[Suppl]: 28E-35E. 被引量:1

共引文献44

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部